Skip to content
10-K

Annual Report

MAIA BIOTECHNOLOGY, INC. MAIA

0001493152-26-012088

← back to feed
Filed
Mar 23, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 23, 2026 60.67M sh
Shares Diluted FY 2025 · Dec 31, 2025 32.11M sh
Shares Diluted FY 2025 · Dec 31, 2024 22.2M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$18.84M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$15.7M
Cash And Equivalents FY 2025 · Dec 31, 2025 $0
Cash And Equivalents FY 2025 · Dec 31, 2024 $0
Stockholders Equity FY 2025 · Dec 31, 2025 $2.38M
Stockholders Equity FY 2025 · Dec 31, 2024 $3.63M
Stockholders Equity FY 2025 · Dec 31, 2023 $477.51K
Current Liabilities FY 2025 · Dec 31, 2025 $5.84M
Current Liabilities FY 2025 · Dec 31, 2024 $3.83M
Total Liabilities FY 2025 · Dec 31, 2025 $7.33M
Total Liabilities FY 2025 · Dec 31, 2024 $6.52M
Current Assets FY 2025 · Dec 31, 2025 $9.7M
Current Assets FY 2025 · Dec 31, 2024 $10.15M
Total Assets FY 2025 · Dec 31, 2025 $9.7M
Total Assets FY 2025 · Dec 31, 2024 $10.16M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.70
Eps Diluted FY 2025 · Dec 31, 2024 −$1.05
Eps Basic FY 2025 · Dec 31, 2025 −$0.70
Eps Basic FY 2025 · Dec 31, 2024 −$1.05
Sga Expense FY 2025 · Dec 31, 2025 $9.72M
Sga Expense FY 2025 · Dec 31, 2024 $6.95M
Rd Expense FY 2025 · Dec 31, 2025 $453.75K
Net Income FY 2025 · Dec 31, 2025 −$22.4M
Net Income FY 2025 · Dec 31, 2024 −$23.25M
Operating Income FY 2025 · Dec 31, 2025 −$24.27M
Operating Income FY 2025 · Dec 31, 2024 −$16.96M